Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:14 PM
Ignite Modification Date:
2025-12-24 @ 3:14 PM
NCT ID:
NCT05988892
Eligibility Criteria:
Inclusion Criteria:
* Adult, cancer survivors (no active disease) at Mayo Clinic Health System (MCHS) in Northwest Wisconsin (NWWI), Southwest Wisconsin (SWWI), Southeast Minnesota (SEMN), or Southwest Minnesota (SWMN)
* Any stage cancer
* Age ≥18 years residing at a rural address (as defined by Rural America, census.gov)
* Completed active treatment of surgery, (neo)adjuvant chemotherapy, and/or (neo) adjuvant radiation. Patients receiving adjuvant endocrine therapy, targeted therapy, or immunotherapy therapies are eligible.
* Ownership of a computer/tablet/smartphone with internet access.
* Willingness to create a google account and maintain the account for use of the Fitbit
* Willingness and ability to attend study visits.
* Must be able to complete semi-tandem (10 seconds), side-by-side tandem \[10 seconds and short physical performance batters(SPPB)\] Score of 6 or greater to qualify for virtual exercise.
* Must be ambulatory without the use of assisted device(s).
Exclusion Criteria:
* Receiving surgery, (neo)adjuvant chemotherapy, (neo) adjuvant radiation, palliative treatment
* Are already performing \>150 minutes/week of moderate activity or 75 min/week of vigorous physical activity
* Cancer-free for greater than 5 years
* Unable to complete weekly interventions/exercise due to traveling or unable to be active for more than 7 consecutive days.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05988892
Study Brief:
Protocol Section:
NCT05988892